Chief Financial Officer

Senior Vice President CMC Development

Alnylam begins global Phase 3 trial dosing of zilebesiran

Cambridge-based Alnylam Pharmaceuticals pulls TV ad after Trump crackdown on drug industry spots

Alnylam Pharmaceuticals Insider Sold Shares Worth $4,034,085, According to a Recent SEC Filing

Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran

Business Account Executive

Alnylam Pharmaceuticals is a leader in RNAi therapeutics, focusing on transforming the lives of people with rare and common diseases. They are seeking experienced Business Account Executives to promote AMVUTTRA™, targeting healthcare providers to enhance market knowledge and drive product adoption. The role involves developing account plans, collaborating with internal and external stakeholders, and achieving business objectives in the specialty pharmaceutical space.

Business Account Executive, TTR - Dallas

Senior Director Executive Sales Lead - East 

Business Account Executive Rare Disease

Business Account Executive - Rare Diseases (PH1 & AHP)

Business Account Executive-Ultra Rare Disease- PH1- Neph/Uro/Ped. Neph/Ped. Ur/AHP-Hem/Oncs/Gastros 

Sign up with Google

Sign in with Google